Dr. Tripathy on Known Elements of COVID-19

Video

In Partnership With:

Debu Tripathy, MD, professor and chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses known elements of COVID-19.

Debu Tripathy, MD, professor and chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses known elements of COVID-19.

The impact of the novel COVID-19 is largely unknown at this point, says Tripathy. However, it seems as though COVID-19, which is more widespread than past viral outbreaks such as Ebola, does not have as high a morality rate. Currently, the mortality rate is estimated to range between 1% and 3%. However, in orders of magnitude, the mortality rate is higher than the flu, says Tripathy.

Additionally, it appears that a group of asymptomatic patients can be carriers and be contagious, which may make containment difficult.

The virus will undoubtedly impact the way the world lives in the short-term, adds Tripathy. Whether the virus is on a trajectory to impact life in the long-term has yet to be seen. However, amplified testing and awareness could help reduce further spread, concludes Tripathy.

Related Videos
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center